SANOFI has 48 disclosed EU lobbying meetings from 2024-07-24 to 2026-05-28: 29 with the European Commission and 19 with Members of the European Parliament. Source: EU Transparency Register no. 61291462764-77, Commission disclosures and MEP declarations. Methodology
SANOFI
EU lobbying footprint — who they meet, and on what.
- Register no.
- 61291462764-77 ↗
- Disclosed meetings
- 48 (29 Commission · 19 MEP)
- Period
- 2024-07-24 → 2026-05-28
Declared fields of interest: Business and industry · Climate action · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · External relations · Humanitarian aid and civil protection · Institutional affairs
Lobbying profile
as declared 2026-03-18- Category
- Companies & groups
- Legal status
- Public limited company
- Declared lobbying cost
- €1,500,000
- Lobbying FTEs
- 2.5
- Members
- 2
At a glance
- Health10
- Technology6
- Stéphane Séjourné2
- Maurice Whelan2
- Tobias Wiesenthal2
- Olivér Várhelyi1
- Maria Pilar Aguar Fernandez1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- Biotech Actsource ↗
- Biotech Act Isource ↗
- 2026-04-09ECMaria Pilar Aguar Fernandez · DirectorSanofi’s research and development (R&D) strategy in the European context.source ↗
- Biotech Actsource ↗
- Biotech Actsource ↗
- Health policysource ↗
- 2026-02-03ECCarmen Laplaza Santos · Head of UnitExchange of views on the competitiveness of the European pharmaceutical sector.source ↗
- 2026-01-28ECVita Jukne · Cabinet of Commissioner Jessika RoswallImplication of REACH revision and the upcoming Per- and Polyfluoroalkyl Substances (PFAS)source ↗
- Site visitsource ↗
- Cardiovascular Healthsource ↗
- 2025-12-05ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane SéjournéIndustrie pharmaceutique, innovation et souveraineté sanitaire européenne.source ↗
- 2025-10-28ECDorota Denning · Cabinet of Commissioner Valdis DombrovskisRoundtable on Simplification for Pharmaceutical Innovationsource ↗
- Competiveness in the Healthcare sectorsource ↗
- 2025-09-10ECCecile Billaux · Head of UnitOverview of Sanofi’s actions in global health and on local manufacturing in Africasource ↗
- 2025-09-05ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane Séjourné- Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EUsource ↗
- 2025-09-04ECLucilla Sioli · DirectorVirtual Human Twinssource ↗
- 2025-09-04ECSaila Rinne · Head of UnitVirtual Human Twinssource ↗
- 2025-09-04ECRainer Becker · DirectorExchange of views on multinational clinical trials in the context of the upcoming Biotech Actsource ↗
- 2025-07-29ECFlorika Fink-Hooijer · Director-GeneralHealth security and innovation across Europe, SANOFI’s relevant activitiessource ↗
- 2025-07-15ECMarco Marsella · DirectorThe Digital Human. This flagship program leverages AI-driven avatars and advanced health data solutions.source ↗
- 2025-07-08ECVilija Sysaite · Cabinet of Executive Vice-President Stéphane SéjournéChallenges of Sanofi in Europe and opportunities to enhance investment and innovation in the pharmaceutical sectorsource ↗
- 2025-06-26ECSacha Halphen · Cabinet of Executive Vice-President Stéphane SéjournéCompétitivité; relations USE-UE, CSRD/CS3D, Simplificationsource ↗
- 2025-06-05ECKerstin Jorna · Director-GeneralChallenges for the EU pharmaceutical industrysource ↗
- 2025-06-03ECGabriela Tschirkova · Cabinet of Commissioner Valdis DombrovskisSimplificationsource ↗
- 2025-06-03ECMichael Hager · Cabinet of Commissioner Valdis DombrovskisCompetitiveness of the pharmaceutical sectorsource ↗
- 2025-05-28ECAnn-Sofie Ronnlund · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2025-05-13ECEgelyn Braun · Cabinet of Commissioner Michael McGrathExchange of views on competitiveness, simplification and collective redresssource ↗
- 2025-04-04ECMaurice Whelan · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-04ECTobias Wiesenthal · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-02ECNicolo Brignoli · Cabinet of Commissioner Valdis DombrovskisCompetitivenesssource ↗
- 2025-03-28ECNatividad Lorenzo · Cabinet of Commissioner Jozef SíkelaGlobal Gatewaysource ↗
- Healthsource ↗
- 2025-03-19ECFelice Zaccheo · Head of UnitTo discuss Sanofi’s involvement in LAC and opportunities for actionable cooperations under the GGIA to contribute to health self-sufficiency in LAC.source ↗
- 2025-03-12ECOlivier Girard · Head of UnitDiscussion on Joint procurement to improve availability of antibiotics and avoid shortagessource ↗
- Health policysource ↗
- Introductory Meetingsource ↗
- Pharmaceutical Industrysource ↗
- 2025-01-27ECTobias Wiesenthal · Head of UnitExploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-01-27ECMaurice Whelan · Head of UnitExploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- European healthcaresource ↗
- European health policysource ↗
- Pharmaceutical sectorsource ↗
- Pharma strategysource ↗
- 2024-09-30ECJosep Borrell Fontelles · Cabinet of High Representative Josep Borrell FontellesThe objective of the lunch is to gather the views of key representatives from the EU private sector regarding the present situation in Mexico and prospects under the new administration, notably from an economic perspective, in an open dialogue.source ↗
- Healthsource ↗
- Health policysource ↗
- Choroby oddechowe w UEsource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has SANOFI disclosed?
SANOFI (EU Transparency Register no. 61291462764-77) appears in 48 disclosed meetings with EU officials and MEPs between 2024-07-24 and 2026-05-28: 29 with the European Commission and 19 with Members of the European Parliament.
What does SANOFI lobby on?
SANOFI's disclosed EU meetings most often concern Health, Technology. Every meeting and its topic is listed with its official source on this page.
Who does SANOFI meet in Brussels?
Across its disclosed meetings, SANOFI has met Commission officials including Stéphane Séjourné, Maurice Whelan, Tobias Wiesenthal, and MEPs including SOKOL Tomislav, KULJA András Tivadar, ANDRIUKAITIS Vytenis Povilas. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 61291462764-77) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.